Literature DB >> 16621439

Treatment attrition during group therapy for social phobia.

Stefan G Hofmann1, Michael Suvak.   

Abstract

Psychological group treatments, such as behavioral or cognitive-behavioral therapy, are generally effective interventions for social phobia. However, a substantial number of individuals discontinue these treatments prematurely. Participant attrition can threaten the validity of treatment outcome studies if attrition during therapy does not occur randomly. In order to examine this issue, we studied 133 individuals with a principal diagnosis of social phobia who initiated a 12-week behavioral or cognitive-behavioral group treatment for social phobia. Thirty-four participants discontinued therapy prematurely. These dropouts were compared to treatment completers in demographic characteristics, Axis I and II psychopathology, and their attitude toward treatment. The results only showed a small difference between treatment completers and dropouts in their attitude toward treatment: dropouts rated the treatment rationale as less logical than completers at the beginning of treatment. No other differences between dropouts and completers were observed. Therefore, dropouts are unlikely to present a serious threat to the external validity of treatment outcome studies for social phobia.

Entities:  

Mesh:

Year:  2006        PMID: 16621439     DOI: 10.1016/j.janxdis.2006.03.005

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  13 in total

1.  Factors associated with attrition from a randomized controlled trial of meaning-centered group psychotherapy for patients with advanced cancer.

Authors:  Allison J Applebaum; Wendy G Lichtenthal; Hayley A Pessin; Julia N Radomski; N Simay Gökbayrak; Aviva M Katz; Barry Rosenfeld; William Breitbart
Journal:  Psychooncology       Date:  2011-07-12       Impact factor: 3.894

2.  Cognitive therapy for depressed adults with comorbid social phobia.

Authors:  Jasper A J Smits; Abu Minhajuddin; Robin B Jarrett
Journal:  J Affect Disord       Date:  2008-09-18       Impact factor: 4.839

3.  Changes in psychosocial well-being after mindfulness-based stress reduction: a prospective cohort study.

Authors:  Renee J Hill; Lindsey C McKernan; Li Wang; Rogelio A Coronado
Journal:  J Man Manip Ther       Date:  2017-05-04

4.  Sudden gains during therapy of social phobia.

Authors:  Stefan G Hofmann; Stefan M Schulz; Alicia E Meuret; David A Moscovitch; Michael Suvak
Journal:  J Consult Clin Psychol       Date:  2006-08

5.  Time course of treatment dropout in cognitive-behavioral therapies for posttraumatic stress disorder.

Authors:  Cassidy A Gutner; Matthew W Gallagher; Aaron S Baker; Denise M Sloan; Patricia A Resick
Journal:  Psychol Trauma       Date:  2015-06-22

6.  Attrition and attendance in group therapy for university students: An examination of predictors across time.

Authors:  Tahira Gulamani; Amanda A Uliaszek; Carla D Chugani; Tayyab Rashid
Journal:  J Clin Psychol       Date:  2020-08-24

7.  Treating individuals with social anxiety disorder and at-risk drinking: phasing in a brief alcohol intervention following paroxetine.

Authors:  Sarah W Book; Suzanne E Thomas; Joshua P Smith; Patrick K Randall; Matt G Kushner; Gail A Bernstein; Sheila M Specker; Peter M Miller; Carrie L Randall
Journal:  J Anxiety Disord       Date:  2013-03-04

Review 8.  Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.

Authors:  Joseph F McGuire; Adam B Lewin; Eric A Storch
Journal:  Expert Rev Neurother       Date:  2014-06-27       Impact factor: 4.618

9.  A review of studies concerning treatment adherence of patients with anxiety disorders.

Authors:  Lívia Santana; Leonardo F Fontenelle
Journal:  Patient Prefer Adherence       Date:  2011-08-23       Impact factor: 2.711

Review 10.  Psychological group-treatments of social anxiety disorder: a meta-analysis.

Authors:  Hanna Wersebe; Marit Sijbrandij; Pim Cuijpers
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.